2480 — Beijing Luzhu Biotechnology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$4.42bn
- HK$4.01bn
Annual cashflow statement for Beijing Luzhu Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -539 | -725 | -249 | -168 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 512 | 640 | 45 | 14.2 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 1.98 | -1.82 | -1.72 | 42.9 |
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -19.2 | -77.3 | -190 | -86.1 |
| Capital Expenditures | -78.5 | -257 | -87.1 | -98.4 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -325 | 33.8 | 186 | 50.8 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -404 | -223 | 98.6 | -47.6 |
| Financing Cash Flow Items | 443 | 329 | -34 | -0.664 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 455 | 337 | 273 | 14.9 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 31.8 | 36.9 | 189 | -118 |